MODULATION OF IGF-II IMPRINTING IN THE AGING PROSTATE

前列腺癌的三个重要特征将在本提案中提出，这将提高我们对前列腺癌发生的危险因素的理解。这些特征包括：i)前列腺癌的多灶性，这意味着癌症易感性的普遍或领域变化，ii)前列腺癌发展的年龄相关性，以及iii)胰岛素样生长因子轴在与衰老和遗传相关的癌症中的重要作用。IGF-II是一种自身旁分泌生长刺激物，是癌症发展的重要正向调节因子。我们提供了初步证据，印记丢失(LOI)，或双等位基因表达，是一种年龄相关的特定表观遗传学改变，发生在人类的外周前列腺。成人组织中IGF-II的印记通常保持不变，LOI是前列腺癌的常见特征。由于DNA甲基化是IGF-II印迹的主要决定因素，我们预计甲基化的变化将与印迹状态的改变相关。我们的假设是，IGF-II中基因组印记的丢失是前列腺上皮细胞中与年龄相关的事件，可能受到DNA甲基化变化的调节。在特定的目标1中，我们将确定在老化的小鼠前列腺中是否存在IGF-II的LOI。在特定目标2中，将评估加速DNA甲基化丢失对小鼠和体外人类模型印迹的影响。具体目标3将确定这些机制和/或其他机制是否会导致衰老过程中IGF-II表达的增加。这一建议意义重大且新颖，因为它能够在体内衰老过程、饮食和前列腺癌发生之间提供关键的表观遗传学联系。我们希望确定IGF-II印迹是否随着年龄的增长而改变，以及DNA甲基化改变是否是导致这一变化的潜在机制。即使在不太可能的情况下，IGF-II在前列腺癌的发生中只起到很小的作用，这一建议代表了一种新的和重要的方法来评估表观遗传场的变化，这可能解释前列腺癌的年龄、器官和饮食相关的特异性。

Three important features of prostate cancer will be addressed in the present proposal that will improve our understanding of risk factors for the development of prostate cancer. These features include: i) the multifocality of prostate cancer which implicates a generalized or field change in cancer susceptibility, ii) the age-dependence of prostate cancer development, and iii) the important role of the Insulin-like Growth Factor Axis in both aging-related and genetic-related cancers. IGF-II is an auto-paracrine growth stimulator that is an important positive modulator of cancer development. We provide preliminary evidence that a loss of imprinting (LOI), or biallelic expression, is an age-related specific epigenetic alteration that occurs in the peripheral prostate of the human. The imprinting of IGF-II in adult tissues is typically maintained and LOI is a common attribute of prostate cancers. Since DNA methylation is a major determinant of IGF-II imprinting we would anticipate that changes in methylation would be associated with altered imprinting status. It is our hypothesis to be tested that a loss of genomic imprinting in IGF-II is an age-related event in prostate epithelial cells and may be modulated by changes in DNA methylation. In Specific Aim 1, we will determine if a LOI of IGF-II occurs in the aging mouse prostate. In Specific Aim 2, the impact of accelerating DNA methylation loss on imprinting in mouse and an in vitro human model will be assessed. Specific Aim 3 will determine whether these mechanisms, and/or others, engender the increase in IGF-II expression seen in aging. This proposal is significant and novel in that it has the ability to provide a critical epigenetic link between the aging process, diet and prostate carcinogenesis in vivo. We expect to determine whether IGF-II imprinting is altered with aging and whether altered DNA methylation is an underlying mechanism for this. Even in the unlikely event the IGF-II plays only a minor role in prostate carcinogenesis, this proposal represents a novel and important methodological approach to evaluating epigenetic field changes that may explain the age-, organ- and diet-related specificity of prostate cancer.